Peptomyc - NEWS

Peptomyc S.L. secures 4.2 Million Euros in Series A led by Alta Life Sciences

peptomyc_20152022-11-04T12:33:52+00:0006 / 09 / 17|

Peptomyc selected by L’Econòmic as a potential unicorn

peptomyc_20152022-11-04T12:33:58+00:0013 / 07 / 17|

Peptomyc receives 212000 euros from the Spanish Centre for the Development of Industrial Technology (CDTI)

peptomyc_20152022-11-04T12:34:04+00:0003 / 05 / 17|

Peptomyc receives further support from Spanish Ministry Mineco

peptomyc_20152022-11-04T12:34:09+00:0025 / 04 / 17|

Peptomyc wins Startup Slam competition at BIO-Europe Spring® Barcelona

peptomyc_20152022-11-04T12:34:14+00:0025 / 03 / 17|

Neruda Scott (Johnson & Johnson), Bauke Anninga (Innovation Forum), Laura Soucek (Peptomyc) and Emma Kohring (Johnson & Johnson).

Panel of expert judges selects winner from 14 short-listed European start-ups that showed greatest potential for transformative healthcare solutions

Startup Slam sponsor and co-host Johnson & Johnson Innovation recognizes high caliber of entries selected to compete for prestigious award

[…]

Peptomyc is proud to join CatalonioBio

peptomyc_20152022-11-04T12:34:19+00:0024 / 03 / 17|

Peptomyc receives 850K € from Spanish Mineco and European Commission joint fund

peptomyc_20152022-11-04T12:34:24+00:0030 / 11 / 16|

Peptomyc wins prize at EIT Health Summit

peptomyc_20152022-11-04T12:34:29+00:0023 / 11 / 16|

Peptomyc completed a successful and constructive Briefing Meeting with the Innovation Task Force of the European Medicines Agency (EMA) at their headquarters in London, U.K.

peptomyc_20152022-11-04T12:34:35+00:0019 / 09 / 16|

Peptomyc completes Seed Funding of €1M

peptomyc_20152022-11-04T12:34:39+00:0027 / 04 / 16|

Funds will help company reach preclinical validation for lead candidate in glioblastoma – an aggressive and lethal brain tumor – and in other cancer indications.

[…]

Previous 3 456 Next